Sustained activation of nuclear erythroid 2-related factor 2/antioxidant response element signaling promotes reductive stress in the human mutant protein aggregation cardiomyopathy in mice
about
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanismTargeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of CardiologyGenetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survivalParadoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health ImplicationsMechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative diseaseRedox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics.Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training.Nrf2 enhances myocardial clearance of toxic ubiquitinated proteinsIdentification of peptides in human Hsp20 and Hsp27 that possess molecular chaperone and anti-apoptotic activitiesReductive potential - a savior turns stressor in protein aggregation cardiomyopathyFumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.Proteostasis and REDOX state in the heart.Small heat shock proteins in redox metabolism: implications for cardiovascular diseases.Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed miceReductive stress linked to small HSPs, G6PD, and Nrf2 pathways in heart diseaseAbrogation of Nrf2 impairs antioxidant signaling and promotes atrial hypertrophy in response to high-intensity exercise stress.Disruption of nuclear factor (erythroid-derived-2)-like 2 antioxidant signaling: a mechanism for impaired activation of stem cells and delayed regeneration of skeletal muscleLoss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac FibroblastsAcute exercise stress activates Nrf2/ARE signaling and promotes antioxidant mechanisms in the myocardium.Nrf2 and cardiovascular defense.Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases.Contribution of small heat shock proteins to muscle development and function.Role of the Nrf2 signaling system in health and disease.Heme oxygenase-1: an emerging therapeutic target to curb cardiac pathology.Diabetic cardiomyopathy and its prevention by nrf2: current status.KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity.Nuclear factor erythroid-2 related factor 2 (Nrf2)-mediated protein quality control in cardiomyocytes.Mediterranean diet and inflammaging within the hormesis paradigm.Constitutive activation of Nrf2 induces a stable reductive state in the mouse myocardium.Responses to reductive stress in the cardiovascular system.Aggregate-prone R120GCRYAB triggers multifaceted modifications of the thioredoxin system.Identification of transcriptome signature for myocardial reductive stress.Nrf2 deficiency promotes apoptosis and impairs PAX7/MyoD expression in aging skeletal muscle cells.The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus.Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy.Reductive Stress in Inflammation-Associated Diseases and the Pro-Oxidant Effect of Antioxidant Agents.Increasing autophagy and blocking Nrf2 suppress laminopathy-induced age-dependent cardiac dysfunction and shortened lifespan.NRF2 Induction for NASH Treatment: A New Hope Rises.Carnosic acid promotes myocardial antioxidant response and prevents isoproterenol-induced myocardial oxidative stress and apoptosis in mice.
P2860
Q26751266-8AE5699F-D849-41DE-B55F-EB94A6FF3977Q27024879-09F9DCA5-15C4-4417-BAF0-7B2EF073A7FEQ28385079-B3ECB018-EA06-49D6-B9EC-C9FD0AE1AF30Q28392715-A017DB3F-4ADF-487D-AA9B-DAA3F8AC2617Q28394732-2A34FE71-6381-4942-9D79-1EEB88A23831Q33702016-490D4DA5-2B8F-49BB-AC7A-4103831A1E62Q34317717-BB94DBF8-F4D5-4ED6-AD8B-F6549BCF166AQ34429826-C9E49EF2-FEB4-4BC6-9DDA-E78DB616DBA8Q35565746-3AFD6E12-B63A-4090-A4D4-38262A871297Q35586798-D8B5937B-9BC5-4291-848D-D592B243A6A9Q35660306-AF62DAA9-3BDB-4EEB-8F36-F82569939ABFQ35859412-600CAD07-4F80-4EE2-8B3A-6B518584FAECQ35906430-F0DB2C6A-D4D3-44F2-B047-10C894785DB5Q36143828-1937EC47-C09A-43C1-A31B-C5F9DC754F24Q36157579-99A6DEF9-650F-460D-A8E1-16855956A591Q36596623-1E62FD8E-798A-4B48-BDB9-F1610B9E8E65Q36769369-76D57488-0E9C-4464-B4FB-09271AA96B55Q36812068-A534495C-5C7A-4074-86A2-1A48CB57F1D0Q37023604-527F30C7-D1C1-4ADA-A763-BFBB696DC897Q37238575-568CA5FB-291A-4844-853E-60DF71820E40Q38108306-5A9CCC1A-0E0A-489D-A644-F6D49DC48D68Q38167610-B29FD6BD-8151-49EB-8564-0D17ABAF5EA6Q38179729-313088C9-0973-4134-990F-74CF201451A7Q38237494-F670D214-97D7-4AEA-8B2D-12C8444FB7C3Q38262595-BF6E37DC-8812-45F5-80E5-C4A491CC4572Q38263221-EF9C2B4D-998A-4D9B-B53B-0718328BF025Q38553032-E491DF35-A553-419E-86B5-7B2686627E35Q38681132-CD65AF52-A355-46F4-BDBB-81B83612D5E7Q38736064-19A1B782-5C5C-42A9-B730-446824BDD8A6Q38797794-5386DAC4-8B5A-4671-AD77-E67C738ED06DQ39035367-1F9F9BE9-B20B-46BF-93A1-2994828C97F6Q40079761-14C1513C-29C4-4D2A-B0D5-D7AAE98FB82BQ41189456-00D69A60-061B-4124-8650-84648DA73F87Q41311958-003F063E-A823-42A0-9340-6966856AA418Q41623135-E64DC5F2-8973-4369-83B4-3C6E75A91468Q42007004-1BEF1252-9AF1-4A52-9516-A80793996FE0Q43408050-894C9968-8992-4FEC-BA55-C2F173087A31Q51731708-1F1BEF39-CEAD-4C96-BBB3-4E7533EAB08FQ52575751-BCC668FE-4B41-410A-9948-998D880BA569Q53044367-5D8372E1-05E7-4CC5-95CD-4DB8C5043468
P2860
Sustained activation of nuclear erythroid 2-related factor 2/antioxidant response element signaling promotes reductive stress in the human mutant protein aggregation cardiomyopathy in mice
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Sustained activation of nuclea ...... egation cardiomyopathy in mice
@ast
Sustained activation of nuclea ...... egation cardiomyopathy in mice
@en
type
label
Sustained activation of nuclea ...... egation cardiomyopathy in mice
@ast
Sustained activation of nuclea ...... egation cardiomyopathy in mice
@en
prefLabel
Sustained activation of nuclea ...... egation cardiomyopathy in mice
@ast
Sustained activation of nuclea ...... egation cardiomyopathy in mice
@en
P2093
P2860
P356
P1476
Sustained activation of nuclea ...... egation cardiomyopathy in mice
@en
P2093
Christopher J Davidson
Gayatri D Khanderao
Ivor J Benjamin
Jay L Zweier
Matthew A Firpo
Namakkal Soorappan Rajasekaran
Sankaranarayanan Kannan
Saradhadevi Varadharaj
P2860
P304
P356
10.1089/ARS.2010.3587
P577
2011-02-02T00:00:00Z